b r i e f c o m m u n i c a t i o n s
Eosinophilic esophagitis (EoE) is an allergic disorder characterized by the accumulation of eosinophils in the esophagus. We report association of EoE with variants at chromosome 5q22 encompassing TSLP and WDR36 (rs3806932, combined P = 3.19 × 10 −9 ). TSLP is overexpressed in esophageal biopsies from individuals with EoE compared with unaffected individuals, whereas WDR36 expression is unaltered between the two groups. These data implicate the 5q22 locus in the pathogenesis of EoE and identify TSLP as the most likely candidate gene in the region.
EoE is a global health condition now reported on all continents except Africa, with an incidence of ~1 per 10,000 people 1 . Symptoms of EoE include difficulty feeding, failure to thrive, vomiting, epigastric or chest pain, dysphagia and food impaction. Individuals with EoE (cases) are predominantly young males with a high rate of atopic disease, and the diagnosis of EoE is made by endoscopy and biopsy findings of isolated eosinophils in the esophagus 1 .
Based on several findings, EoE is considered a food allergy-related disorder. The majority of EoE cases are atopic individuals with a high rate of food allergen sensitization as determined by skin prick and patch testing; in addition, EoE cases have a higher rate of food anaphylaxis compared with the general population 1 . Moreover, nearly all EoE cases have complete disease remission following introduction of an elemental formula diet that lacks all allergens; conversely, the disease flares upon reintroduction of specific foods. Unlike the situation in classic anaphylaxis, which typically involves a limited set of foods, in EoE affected individuals are often sensitized to a myriad of foods, including food groups not typically associated with eliciting anaphylaxis 2 . Experimental modeling in mice has demonstrated a key role for adaptive immunity and Th2-cell cytokines (especially IL-5 and IL-13) in the disease process and a strong connection between allergic sensitization and inflammation in the respiratory tract and skin 3 .
Accumulating evidence suggests that EoE has a strong familial association 4 . Nearly 10% of parents of EoE cases have a history of esophageal strictures, and ~8% have biopsy-proven EoE 4 ; in addition, at least 27 multiplex EoE families have been described to date 5 , wherein multiple family members are affected. EoE also exhibits a high sibling risk ratio (λ S ) of ~80 compared with related atopic diseases such as asthma (λ S ~ 2) 6 . Although genetics is likely to have a large role in EoE susceptibility, there has been only one candidate gene identified to date, CCL26 (encoding eotaxin-3), which is the most highly overexpressed gene in the esophagus of EoE cases based on genome-wide expression profiling 7 . However, the disease-associated allele is only present in 14% of EoE cases 7 , suggesting that additional risk variants are yet to be found.
We report the results of an ongoing genome-wide association study (GWAS) aimed at identifying susceptibility loci for EoE. We genotyped approximately 550,000 SNPs on the Illumina HumanHap550 BeadChip in a discovery cohort of 181 EoE cases from Cincinnati Children's Hospital Medical Center (CCHMC) and 1,974 unaffected individuals (controls) from the Children's Hospital of Philadelphia (CHOP), and in a replication cohort of 170 EoE cases and 1,130 controls from CHOP (see Supplementary Methods for quality-control measures and detailed descriptions of cases and controls). The study was approved by the institutional review boards of CHOP and CCHMC. Parental informed consent was obtained from all participants in this study for the purpose of DNA collection and genotyping.
Both cases and controls were chosen based on their self-reported ancestry; however, to avoid any population stratification, we screened all samples at ancestry informative markers using the STRUCTURE package (Supplementary Methods and URLs). Cases were subsequently genetically matched to controls by principal component analysis (Supplementary Methods). Single marker analyses for genome-wide data were carried out using the Cochran-Armitage trend test as implemented in PLINK.
In the discovery cohort, two SNPs remained significantly associated with EoE following correction for multiple testing ( Supplementary  Fig. 1a) . One of the two SNPs, rs3806932 (uncorrected P = 8. Fig. 2 ; averaged recombination rates from the CEU HapMap trios shown in Fig. 1) .
We next sought to replicate our findings in the CHOP EoE cohort. Although none of the SNPs surpassed genome-wide significance (Supplementary Fig. 1b) , of the 12 EoE-associated SNPs at the 5q22.1 locus in the discovery cohort, 4 were also associated with EoE in the replication cohort (P value range of 0.05 to 4.8 × 10 −3 ; OR range = 0.70-1.3) ( Table 1) . Combining the P values across the two cohorts using Fisher's method, three SNPs surpassed genomewide significance (P value range of 2.37 × 10 −8 to 3.19 × 10 −9 ). The most significant SNP in the discovery cohort, rs3806932, was also significantly associated in the replication cohort (P = 8 × 10 −3 ; minor allele frequency of 37.7% in cases and 45.2% in controls; OR = 0.73; combined P value for rs3806932 across CCHMC and CHOP cohorts = 3.19 × 10 −9 ).
In addition to the 5q22.1 locus, one SNP on 13q31.1, rs1873288, reached genome-wide significance in the discovery cohort (P = 6.72 × 10 −8 ) but did not replicate in the CHOP cohort. We subsequently performed a genome-wide meta-analysis of the discovery and replication cohorts (Supplementary Fig. 1c) . Besides the 5q22.1 locus, one SNP on chromosome 16 (rs371915, P = 2.19 × 10 −8 ) also reached genome-wide significance; however, this association remains to be replicated in future studies. A summary of all the meta-analysis SNPs with P < 1 × 10 −5 is shown in Supplementary Table 2 ; it is notable that the list includes SNPs that map to genes that have previously been implicated in immune function such as STAT6 (rs167769) and DSG1 (rs7236477).
Finally, as the proportion of EoE cases with asthma is high (~40% in the CCHMC cohort and ~20% in the CHOP cohort), we carried out a logistic regression analysis including asthma status as a covariate in the analysis of both cohorts to ensure that the result was not being driven by asthma rather than EoE. We observed consistent association at the 5q22 locus (Supplementary Table 1 ) with no significant heterogeneity in the odds ratios after adjusting for asthma status, which indicates that the association is independent of asthma.
We subsequently examined the expression levels of both TSLP and WDR36 mRNA in esophageal biopsies from EoE cases and controls. TSLP was significantly overexpressed in EoE cases compared to controls following normalization with GAPDH, whereas WDR36 was unaltered (Fig. 1b,c) . We then investigated the expression of the two TSLP isoforms (Supplementary Fig. 3 ) in the esophageal biopsies. TSLP isoform 2 was significantly overexpressed in EoE cases compared to controls (P < 0.0001). Finally, TSLP expression levels were significantly correlated with rs3806932 genotype in the EoE cases; homozygote carriers of the protective minor allele showed less TSLP expression than heterozygotes and homozygotes for the ancestral allele ( Fig. 1d and Supplementary Fig. 4) . These results indicate that TSLP is the stronger candidate at the 5q22 locus in influencing EoE susceptibility.
Taken together, we have identified and replicated a genomewide significant locus at 5q22.1 in EoE cases of European ancestry. Two genes map to this locus, TSLP and WDR36. WDR36 is highly coregulated with the T-cell growth factor IL-2 and has also been linked to open-angle glaucoma 8 . TSLP encodes an IL-7-like cytokine that is expressed in the thymus and peripheral tissues and that regulates dendritic cell-mediated inflammatory Th2 responses 9 . As a key initiator of allergic inflammatory diseases, TSLP is overproduced in lesional skin in atopic dermatitis and the asthma-affected lung. In mouse models of allergic airway inflammation, enhanced Tslp production from skin keratinocytes correlates with increased Th2-attracting chemokine 
production (including the chemokines eotaxin-1 and eotaxin-2) and with enhanced disease severity and epicutaneous sensitization 10 . The higher expression of TSLP observed in EoE cases suggests a model in which TSLP acts as a driving force for the allergic phenotype. Indeed, individuals with EoE are highly atopic and highly sensitized to multiple food allergens, and TSLP plays a critical role in initiating allergen sensitization 9 , a process that is profoundly abnormal in EoE cases. In addition, IL-13 has been shown to co-induce TSLP in epithelial cells, and we have previously associated IL-13-driven epithelial responses with EoE pathogenesis 11 . We hypothesize that increased TSLP expression as observed in the EoE cases leads to increased allergen sensitization and to development of EoE. It is noteworthy that the TSLP receptor (cytokine receptor-like factor 2, CRLF2) resides within the pseudoautosomal region 1 on the X and Y chromosomes (Xp22.3 and Yp11.3) 12 , providing a plausible hypothesis to explain the higher incidence of EoE in males. Consistent with our analysis, a recent GWAS has identified several SNPs associated with peripheral blood eosinophilia, including SNPs in the 5q22 locus 13 . EoE can associate with peripheral blood eosinophilia but only in a subset of individuals 14 . This suggests that EoE and peripheral eosinophilia are associated with the same locus.
In conclusion, we report the first EoE susceptibility locus identified using a GWAS approach and implicate TSLP as a promising candidate gene underlying this association.
URLs. STRUCTURE, http://pritch.bsd.uchicago.edu/structure.html; PLINK, http://pngu.mgh.harvard.edu/~purcell/plink/.
Note: Supplementary information is available on the Nature Genetics website.
